StockTipsArenaBeta

BUY Laurus Labs Ltd — Chandan Taparia, Motilal Oswal

BUYLaurus Labs Ltd
Laurus Labs share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))9 Nov 2026via LiveMint Markets

Entry₹2,480Inferred
Target₹2,600
Total upside +4.84%
Stop loss₹2,380-4.03% risk
CMP₹2,4241d ago
Active-2.26%+7.26%upside left 10d left
Follow Chandan Taparia for new calls(36% target hit, 311 closed calls)Get alertsWatch LAURUSLABS for new buy/sell callsGet alertsSee 281 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:33 am IST
12 supporting2 neutral1 opposing
Supports the BUY call (12)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

Laurus Labs share price at record high after Q2 results 20⁠⁩26, dividend announcement - Should you buy pharma stock?

NewsLivemint·30 Oct · 2w ago

(opens in new tab)

Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY

NewsEt-Markets·30 Oct · 2w ago

(opens in new tab)

Laurus Labs hits 52-week high as strong Q2 results fuel buying

NewsHbl·30 Oct · 2w ago

(opens in new tab)

Laurus Labs Q2 Review: Brokerages Split As Jefferies Raises Target, Two Retain Sell

NewsNdtv-Profit·30 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Sensex, Nifty extend gains for 2nd day: IT stocks lead rally, broader market underperforms

NewsCnbc-Tv18·30 Oct · 2w ago

(opens in new tab)

Laurus Labs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·29 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

RSI at 78 — overbought territory

Technicals · rsi·14 Nov · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Laurus Labs

All analyst calls on Laurus Labs

More from Chandan Taparia, Motilal Oswal

Every call and its outcome